An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person who started semaglutide for type 2 diabetes says they felt less "food noise" (thinking about food) after the first small shot, but after the second shot the intense food thoughts came back. They still aren’t binging as badly as before, but they’re eating around 3,000 calories a day and want to know when things might change. Semaglutide is the drug in medicines like Ozempic and Wegovy. In simple terms, it acts like a natural gut hormone that talks to the brain about hunger and fullness. Clinically, it helps lower blood sugar and can reduce appetite and food intake for many people. It’s given as a weekly injection and treatment usually starts at a low dose to reduce side effects like nausea, then the dose is increased slowly over weeks. This report is an individual’s experience — an anecdote, not a clinical trial. Clinical studies show semaglutide often lowers appetite and body weight over weeks to months, but responses vary a lot between people and across dosing steps. Early on, many people get nausea or less interest in food, and that can affect eating. That effect can be inconsistent: nausea might fade while appetite changes lag or fluctuate. A single person saying their food thoughts returned after the second shot doesn’t mean the drug won’t work long-term; it means individual timing and side effects can be unpredictable. Why this matters is practical. If you or someone is starting semaglutide, it’s realistic to expect some early side effects and variable appetite changes. It often takes several weeks at an effective dose to see steady, meaningful shifts in eating behavior and weight. For people with type 2 diabetes, improved blood sugar control is another key goal, separate from appetite effects. So someone worrying that a temporary return of food thoughts means failure should know that this can be part of the normal adjustment process. There are important caveats. Semaglutide can cause nausea, vomiting, diarrhea, constipation, and sometimes more serious issues like pancreatitis or gallbladder problems in rare cases. It’s prescription-only and should be used under medical supervision, especially for people with certain thyroid conditions or a history of pancreatitis. Also, long-term effects and how it changes behavior vary; if eating remains excessive or you feel unsafe, talk to your clinician for dose adjustments, support, or alternative strategies. Finally, a single anecdote can’t predict others’ results, and patience plus clinical follow-up is often needed. Bottom line: it’s common for appetite and side effects to vary early in semaglutide treatment, and one setback doesn’t mean the drug won’t help — but stay in touch with your doctor to manage symptoms and expectations.
Source: r/Semaglutide